HK Stock Market Move | NUOBIKAN(02635) rose more than 9% during the trading day, AI's pioneering solution empowers the intelligent upgrade of the petrochemical industry.
Noble Group (02635) rose more than 9% in midday trading, reaching a high of HK$514.5, setting a new record high. As of the time of writing, it is up 8.7% to HK$512, with a turnover of HK$164.746 million.
NUOBIKAN (02635) rose over 9% intraday, reaching a high of HK$514.5, setting a new record high. As of the time of writing, it is up 8.7% at HK$512, with a trading volume of HK$16.4746 million.
Public data shows that NUOBIKAN Technology was established in 2015, focusing on advanced technologies such as artificial intelligence and digital twinning. The company specializes in industrial applications in fields such as AI + transportation, AI + energy, and AI + urban governance, providing integrated solutions based on AI industry models. The company's self-developed NBK-INTARI artificial intelligence platform enables customers in the fields of transportation, energy, and urban governance to achieve intelligent monitoring, detection, and operation.
It is worth noting that NUOBIKAN's self-developed "Intelligent Siasun Robot & Automation Inspection and Operation Assistance System for Petrochemical Substations" has created a cost-effective industry demonstration model for operations and maintenance work at the Hainan refinery and substation. Building on the benchmark project in Hainan, NUOBIKAN is closely following the layout of "AI + petrochemicals" by central enterprises such as PetroChina and China Petroleum & Chemical Corporation, while continuing to deepen research and development in "AI + embodied intelligence" technology, focusing on improving stable operation capabilities under extreme conditions.
Related Articles

EVEREST MED (01952) Weishiping has been approved by the National Medical Products Administration to be launched, opening a new era of oral treatment for moderate to severe ulcerative colitis.

Toyota Motor Corp. Sponsored ADR (TM.US) raised its full-year profit guidance. CFO Kenichiro Ito will take over as CEO.

HK Stock Market Move | WESTCHINACEMENT (02233) falls by nearly 10% again, planning to issue 300 million US dollars of preferred notes to repurchase 2026 notes.
EVEREST MED (01952) Weishiping has been approved by the National Medical Products Administration to be launched, opening a new era of oral treatment for moderate to severe ulcerative colitis.

Toyota Motor Corp. Sponsored ADR (TM.US) raised its full-year profit guidance. CFO Kenichiro Ito will take over as CEO.

HK Stock Market Move | WESTCHINACEMENT (02233) falls by nearly 10% again, planning to issue 300 million US dollars of preferred notes to repurchase 2026 notes.






